AZD9291 US Expanded Access Program



Status:No longer available
Healthy:No
Age Range:18 - 127
Updated:7/15/2016

Use our guide to learn which trials are right for you!

A Multi-center, AZD9291 Expanded Access Program for the Treatment of Patients With Advanced/Metastatic EGFR T790M Mutation-positive Non-small Cell Lung Cancer (NSCLC) Who Have Received Prior EGFR TKI Therapy

To provide access to AZD9291 for adult patients with advanced/metastatic, epidermal growth
factor receptor T790M mutation-positive non-small cell lung cancer.

- This is a multi-center, AZD9291 expanded access protocol for the treatment of adult
patients with advanced/metastatic EGFR T790M mutation-positive non-small cell lung cancer
(NSCLC) who have received prior EGFR TKI therapy and at least one additional line of therapy
(≥ 3rd line). Local testing is accepted for confirmation of T790 mutation status. Eligible
patients will be enrolled to receive AZD9291 (80mg orally, once daily) for as long as the
access program remains open and they are continuing to show clinical benefit, as judged by
the treating physician

Inclusion Criteria:

- Provision of signed and dated, written informed consent prior to any treatment
protocol-specific procedures

- Patients aged at least 18 years

- Locally advanced or metastatic EGFRm NSCLC, not amenable to curative surgery or
radiotherapy with confirmation of the presence of the T790M mutation

- Two lines of prior therapy including at least one EGFR TKI

- World Health Organization (WHO) performance status 0-2.

- Females of child-bearing potential must use adequate contraceptive measures, not be
breast-feeding and have negative pregnancy test prior to start of dosing.

- Males patients should be willing to use barrier contraception.

Exclusion Criteria:

- Previous treatment with AZD9291

- Patients currently receiving (or unable to stop use at least 1 week prior to
receiving the first dose of AZD9291) any treatment known to be potent inhibitors or
inducers of CYP3A4

- Any evidence of severe or uncontrolled systemic diseases, including uncontrolled
hypertension, active bleeding diatheses, or significantly impaired bone marrow
reserve or organ function, including hepatic and renal impairment, which in the
clinician's opinion would significantly alter the risk/benefit balance, or active
infection including hepatitis B, hepatitis C and human immunodeficiency virus (HIV).

- Patients with symptomatic CNS metastases who are neurologically unstable

- Past medical history of ILD, drug-induced ILD, radiation pneumonitis requiring
steroid treatment, or any evidence of clinically active ILD

- Any of the following cardiac criteria:

1. Mean resting corrected QT interval (QTc using Fredericia's formula) > 470 msec

2. Any clinically important abnormalities in rhythm, conduction or morphology of
resting ECG (e.g., complete left bundle branch block, third degree heart block,
second degree heart block)

3. Any factors that increase the risk of QTc prolongation or risk of arrhythmic
events such as heart failure, hypokalemia, congenital long QT syndrome, family
history of long QT syndrome or unexplained sudden death under 40 years of age in
first degree relatives or any concomitant medication known to prolong the QT
interval

- Any unresolved toxicity from prior therapy Common Terminology Criteria for Adverse
Events (CTCAE) > grade 3 at the time of starting treatment in the access program

- History of hypersensitivity to AZD9291 (or drugs with a similar chemical structure or
class to AZD9291) or any excipients of these agents

- Males and females of reproductive potential who are not using an effective method of
birth control and females who are pregnant or breastfeeding or have a positive (urine
or serum) pregnancy test prior to access program entry
We found this trial at
32
sites
?
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
?
mi
from
Anaheim, CA
Click here to add this to my saved trials
?
mi
from
Athens, GA
Click here to add this to my saved trials
?
mi
from
Austin, TX
Click here to add this to my saved trials
Beverly Hills, California 90211
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
?
mi
from
Boca Raton, FL
Click here to add this to my saved trials
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Buffalo, NY
Click here to add this to my saved trials
?
mi
from
Burbank, CA
Click here to add this to my saved trials
Charlotte, North Carolina 28207
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
?
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Columbus, OH
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
?
mi
from
Detroit, MI
Click here to add this to my saved trials
?
mi
from
Fairfax, VA
Click here to add this to my saved trials
?
mi
from
Fleming Island, FL
Click here to add this to my saved trials
?
mi
from
Fresh Meadows, NY
Click here to add this to my saved trials
?
mi
from
Honolulu, HI
Click here to add this to my saved trials
?
mi
from
Lacey, WA
Click here to add this to my saved trials
?
mi
from
Lansing, MI
Click here to add this to my saved trials
?
mi
from
Lincoln, NE
Click here to add this to my saved trials
?
mi
from
Manchester, CT
Click here to add this to my saved trials
?
mi
from
Mineola, NY
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Paramus, NJ
Click here to add this to my saved trials
?
mi
from
Rochester, MN
Click here to add this to my saved trials
Santa Barbara, California 93105
?
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
?
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
?
mi
from
Seattle, WA
Click here to add this to my saved trials
?
mi
from
Warrenton, VA
Click here to add this to my saved trials
Winston Salem, North Carolina 27157
?
mi
from
Winston Salem, NC
Click here to add this to my saved trials